SI-BONE (SIBN) Competitors

SI-BONE (NASDAQ:SIBN) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Which has preferable earnings & valuation, SIBN or LIVN?

LivaNova has higher revenue and earnings than SI-BONE. SI-BONE is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SI-BONE	$167.18M	4.46	-$43.34M	-$0.76	-23.12
LivaNova	$1.25B	1.81	$17.55M	$1.14	36.60

Do insiders & institutionals have more ownership in SIBN or LIVN?

98.1% of SI-BONE shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 3.9% of SI-BONE shares are held by insiders. Comparatively, 0.3% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in SIBN or LIVN?

LivaNova received 231 more outperform votes than SI-BONE when rated by MarketBeat users. Likewise, 69.72% of users gave LivaNova an outperform vote while only 68.80% of users gave SI-BONE an outperform vote.

Company	Underperform	Outperform
SI-BONE	Outperform Votes 172 68.80%	Underperform Votes 78 31.20%
LivaNova	Outperform Votes 403 69.72%	Underperform Votes 175 30.28%

Does the media favor SIBN or LIVN?

In the previous week, LivaNova had 8 more articles in the media than SI-BONE. MarketBeat recorded 32 mentions for LivaNova and 24 mentions for SI-BONE. SI-BONE's average media sentiment score of 0.31 beat LivaNova's score of -0.16 indicating that SI-BONE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SI-BONE	5 Very Positive mention(s)	6 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	2 Very Positive mention(s)	1 Positive mention(s)	13 Neutral mention(s)	6 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do analysts recommend SIBN or LIVN?

SI-BONE presently has a consensus price target of $24.50, indicating a potential upside of 39.44%. LivaNova has a consensus price target of $62.20, indicating a potential upside of 49.09%. Given LivaNova's higher possible upside, analysts clearly believe LivaNova is more favorable than SI-BONE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
LivaNova	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has more risk and volatility, SIBN or LIVN?

SI-BONE has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

Is SIBN or LIVN more profitable?

LivaNova has a net margin of 1.91% compared to SI-BONE's net margin of -23.82%. LivaNova's return on equity of 13.81% beat SI-BONE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SI-BONE	-23.82%	-22.51%	-16.53%
LivaNova	1.91%	13.81%	7.07%

Summary

LivaNova beats SI-BONE on 12 of the 18 factors compared between the two stocks.